2026 NPPES data Pulmonary Disease Physician NPI 1285602052 MD
Verify on CMS →

IMAD BAHHADY, MD

Pulmonary Disease Physician in TAUNTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 482 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
38%
generic claims · 62% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$107.32
3 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

IMAD BAHHADY, MD filed 3,574 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in TAUNTON, Massachusetts, prescribing 38% generic.

4K
Part D claims, 2023
38%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

IMAD BAHHADY, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

3,574 Top 10% higher than 90% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

IMAD BAHHADY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 3 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about IMAD BAHHADY, MD?

Quality data not reported

NPI registry status

Active

Issued 03/09/2006

NPI 1285602052

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

3,574 145% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

Specialty distribution in Massachusetts

How Pulmonary Disease Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Pulmonary Disease Physician share within Massachusetts

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Pulmonary Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pulmonary Disease Physician ABMS/AOA estimate

Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

IMAD BAHHADY, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 72 WASHINGTON ST STE 2100, TAUNTON, MA, 02780, with a listed phone of (508) 824-7282. NPI 1285602052 was issued on 03/09/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BAHHADY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,574 prescription claims written by this provider, covering 482 Medicare beneficiaries and totaling roughly $1.9 million in drug spend, split 62% brand-name and 38% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

72 WASHINGTON ST STE 2100
TAUNTON, MA 02780

Provider Details

NPI 1285602052
Specialty Pulmonary Disease Physician
Credentials MD
Gender Male
NPI Issued 03/09/2006

Hospital and facility affiliations

Facilities where IMAD BAHHADY, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BRISTOL PULMONARY AND SLEEP MEDICINE P.C.
TAUNTON, MA
JORDAN PHYSICIAN ASSOCIATES INC
PLYMOUTH, MA
LIFESPAN PHYSICIAN GROUP OF MASSACHUSETTS INC
TAUNTON, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for IMAD BAHHADY, MD. Source: openpaymentsdata.cms.gov.

Total received

$107

Largest payer

Inspire Medical Systems, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to IMAD BAHHADY, MD. To verify IMAD BAHHADY, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

IMAD BAHHADY, MD — brand share 62.0%
Specialty average (est.)

62% brand-name claims vs 38% generic, on 3,574 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,574
Total Claims
$1.9M
Total Drug Cost
482
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,082
Total Day Supply
142,779
Brand vs Generic
62% brand / 38% generic
Brand Drug Cost
$1.5M
Antibiotic Claims
170

Patient Demographics

Average Patient Age
72.9 years
Avg HCC Risk Score
1.85
Gender Split
66% female / 34% male
Age Distribution
<65: 74, 65-74: 191, 75-84: 172, 85+: 45

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What IMAD BAHHADY, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
570
Albuterol Sulfate Hfa
Albuterol Sulfate
424
Prednisone
203
Symbicort
Budesonide/Formoterol Fumarate
196
Spiriva Respimat
Tiotropium Bromide
171
Ventolin Hfa
Albuterol Sulfate
161
Montelukast Sodium
156
Breo Ellipta
Fluticasone/Vilanterol
135
Incruse Ellipta
Umeclidinium Bromide
121
Fluticasone Propionate
99

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How IMAD BAHHADY, MD fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

IMAD BAHHADY, MD's 3,574 claims are above the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as BAHHADY.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is IMAD BAHHADY, MD's specialty?
IMAD BAHHADY, MD specializes in Pulmonary Disease Physician and practices in TAUNTON, Massachusetts. Credentials: MD.
How much does IMAD BAHHADY, MD prescribe under Medicare Part D?
In 2023, IMAD BAHHADY, MD wrote 3,574 Medicare Part D claims totaling $1.9M in drug costs for 482 beneficiaries.
Where is IMAD BAHHADY, MD located?
IMAD BAHHADY, MD is located at 72 WASHINGTON ST STE 2100, TAUNTON, MA, 02780. Phone: (508) 824-7282.
What is IMAD BAHHADY, MD's NPI number?
IMAD BAHHADY, MD's National Provider Identifier (NPI) is 1285602052, issued on 03/09/2006.
Does IMAD BAHHADY, MD prescribe more brand-name or generic drugs?
IMAD BAHHADY, MD's prescribing is 62% brand-name and 38% generic drugs by claim count, with $1.5M in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does IMAD BAHHADY, MD prescribe most often?
Based on 2023 Medicare Part D data, IMAD BAHHADY, MD's most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does IMAD BAHHADY, MD accept Medicare?
IMAD BAHHADY, MD appears in CMS Medicare data with 3,574 Part D claims and 482 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify IMAD BAHHADY, MD's credentials?
IMAD BAHHADY, MD's NPI is 1285602052 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology